Further evidence for the lack of association between acetylator phenotype and systemic lupus erythematosus
Open Access
- 1 April 1986
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 29 (4) , 508-514
- https://doi.org/10.1002/art.1780290408
Abstract
An association between host acetylator phenotype and idiopathic systemic lupus erythematosus (SLE) has been sought for over a decade, without a definitive result. We have observed that the frequency of the slow acetylator phenotype was similar in 64 patients with idiopathic SLE (38%), 60 healthy volunteers (50%), and 52 non-SLE medical service patients (44%). The slow acetylator phenotype was not more frequent among subgroups of the SLE patients defined by demographic features or specific manifestations of disease. Our results, as well as a majority of previously published results, do not provide evidence for an association between acetylator phenotype and idiopathic SLE.This publication has 32 references indexed in Scilit:
- The association of the slow acetylator phenotype with bladder cancer.Journal of Medical Genetics, 1983
- Hydrazine and LupusNew England Journal of Medicine, 1980
- Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosusArthritis & Rheumatism, 1979
- Acetylator phenotype in spontaneous SLE and rheumatoid arthritis.Annals of the Rheumatic Diseases, 1979
- Effect of Acetylator Phenotype on the Rate at Which Procainamide Induces Antinuclear Antibodies and the Lupus SyndromeNew England Journal of Medicine, 1978
- Normal distribution of acetylation phenotypes in systemic lupus erythematosusArthritis & Rheumatism, 1978
- Individual Differences in the Disposition of Drugs Metabolised in the BodyClinical Pharmacokinetics, 1978
- Evaluation of the Sulphapyridine Acetylator Phenotyping Test in Healthy Subjects and in Patients with Cardiac and Renal DiseasesActa Medica Scandinavica, 1977
- Spontaneous Systemic Lupus Erythematosus and Acetylator PhenotypeActa Medica Scandinavica, 1977
- Isoniazid acetylatlon rate and development of antinuclear antibodies upon isoniazid treatmentArthritis & Rheumatism, 1971